Given that, this present study provides an in-depth discussion of the important impact of miR-141-3p, an upstream regulator of Keap1-Nrf2 signaling pathway, on paclitaxel resistance in breast cancer cells. This evidence concerns the gene NFE2L2 and breast carcinoma.